Cedilla Therapeutics rallies $25m

Cedilla Therapeutics, a biotechnology company focused on precision oncology, has raised $25 million in funding.

Cedilla Therapeutics, a biotechnology company focused on precision oncology, has raised $25 million in funding. The investors included RA Capital Management, Janus Henderson Investors, Woodline Partners LP, Logos Capital and Third Rock Ventures.

Source: Press Release